MA55503A - Amélioration de la chromatographie d'affinité d'immunoglobulines au moyen d'une floculation de pré-capture - Google Patents
Amélioration de la chromatographie d'affinité d'immunoglobulines au moyen d'une floculation de pré-captureInfo
- Publication number
- MA55503A MA55503A MA055503A MA55503A MA55503A MA 55503 A MA55503 A MA 55503A MA 055503 A MA055503 A MA 055503A MA 55503 A MA55503 A MA 55503A MA 55503 A MA55503 A MA 55503A
- Authority
- MA
- Morocco
- Prior art keywords
- flocculation
- capture
- improvement
- affinity chromatography
- immunoglobulin affinity
- Prior art date
Links
- 108060003951 Immunoglobulin Proteins 0.000 title 1
- 238000001042 affinity chromatography Methods 0.000 title 1
- 238000005189 flocculation Methods 0.000 title 1
- 230000016615 flocculation Effects 0.000 title 1
- 102000018358 immunoglobulin Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/12—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the preparation of the feed
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Water Supply & Treatment (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUP1900112A HU231498B1 (hu) | 2019-04-04 | 2019-04-04 | Immunglobulinok affinitás kromatográfiájának fejlesztése kötést megelőző flokkulálás alkalmazásával |
Publications (1)
Publication Number | Publication Date |
---|---|
MA55503A true MA55503A (fr) | 2022-02-09 |
Family
ID=89992878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA055503A MA55503A (fr) | 2019-04-04 | 2020-03-25 | Amélioration de la chromatographie d'affinité d'immunoglobulines au moyen d'une floculation de pré-capture |
Country Status (12)
Country | Link |
---|---|
US (1) | US20220194981A1 (fr) |
EP (1) | EP3947414A1 (fr) |
JP (1) | JP7333412B2 (fr) |
KR (1) | KR20210149089A (fr) |
CN (1) | CN113710685A (fr) |
AU (1) | AU2020252054A1 (fr) |
BR (1) | BR112021017206A2 (fr) |
CA (1) | CA3130629A1 (fr) |
HU (1) | HU231498B1 (fr) |
MA (1) | MA55503A (fr) |
SA (1) | SA521430291B1 (fr) |
WO (1) | WO2020200980A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11964998B2 (en) * | 2017-08-30 | 2024-04-23 | Fresenius Kabi Deutschland Gmbh | Method for purifying anti-IL-6 receptor antibodies |
TW202233644A (zh) * | 2020-10-30 | 2022-09-01 | 美商建南德克公司 | 用於獲得水解酵素活性率降低的醫藥組成物之純化平台 |
CA3200462A1 (fr) * | 2020-12-18 | 2022-06-23 | Sebastian Damerow | Procedes de purification de proteine repliee fusionnee avec un fc-peptide |
WO2023167852A2 (fr) * | 2022-03-02 | 2023-09-07 | Regeneron Pharmaceuticals, Inc. | Procédés de culture cellulaire pour la production d'anticorps |
CN115430198A (zh) * | 2022-09-21 | 2022-12-06 | 英脉生物医药(杭州)有限公司 | 一种蛋白纯化方法和蛋白纯化*** |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1097945T3 (da) | 1991-03-18 | 2007-11-05 | Univ New York | Monoklonale og kimære antistoffer, der er specifikke for human tumornekrosefaktor |
EP0940468A1 (fr) | 1991-06-14 | 1999-09-08 | Genentech, Inc. | Domaine variable d'un anticorps humanisé |
RO118524B1 (ro) | 1992-11-13 | 2003-06-30 | Idec Pharmaceuticals Corp San | Metoda pentru tratarea unei tulburari legata de celulele b |
US5429746A (en) | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
ATE239041T1 (de) | 1996-02-09 | 2003-05-15 | Basf Ag | Humane antikörper welche an humanen tnfalpha binden |
EP1787999B1 (fr) | 1997-04-07 | 2010-08-04 | Genentech, Inc. | Anti-VEGF anticorps |
JP2001194306A (ja) | 2000-01-06 | 2001-07-19 | Advantest Corp | 化学物質検出方法及び装置 |
SG10201603108QA (en) | 2001-06-26 | 2016-05-30 | Amgen Inc | Antibodies To OPGL |
BRPI0616242A2 (pt) | 2005-09-15 | 2011-06-14 | Wyeth Corp | floculaÇço de proteÍna usando sais |
WO2008127305A2 (fr) | 2006-11-01 | 2008-10-23 | Biogen Idec Ma Inc. | Procédé d'isolement de biomacromolécules utilisant un faible ph et des cations divalents |
BRPI0806367A2 (pt) | 2007-01-22 | 2011-09-06 | Genentech Inc | métodos de purificação de anticorpos |
EP2445925A1 (fr) | 2009-06-25 | 2012-05-02 | Bristol-Myers Squibb Company | Purification de protéines par précipitation de l'acide caprylique (l'acide octanoïque) |
US8691918B2 (en) | 2010-05-17 | 2014-04-08 | Emd Millipore Corporation | Stimulus responsive polymers for the purification of biomolecules |
AR089231A1 (es) | 2011-12-15 | 2014-08-06 | Amgen Inc | Metodo de floculacion |
EP2682168A1 (fr) | 2012-07-02 | 2014-01-08 | Millipore Corporation | Dispositif de tirage et métier à filer |
KR20150123796A (ko) | 2013-02-28 | 2015-11-04 | 에이전시 포 사이언스, 테크놀로지 앤드 리서치 | 크로마틴 결핍 세포 배양 수확물로부터의 항체들의 크로마토그래프 정제 |
EP3004135A4 (fr) | 2013-06-04 | 2016-11-23 | Agency Science Tech & Res | Procédé de purification de protéine |
SG11201607098SA (en) | 2014-02-27 | 2016-09-29 | Agency Science Tech & Res | Antibody purification process |
WO2015135884A1 (fr) * | 2014-03-10 | 2015-09-17 | Richter Gedeon Nyrt. | Purification d'immunoglobuline à l'aide d'étapes de pré-nettoyage |
US20180105555A1 (en) | 2015-03-20 | 2018-04-19 | Bristol-Myers Squibb Company | Use of dextran for protein purification |
US10927145B2 (en) * | 2016-06-15 | 2021-02-23 | Agency For Science, Technology And Research | Method of enhancing the performance of chromatography methods for purification of proteins |
-
2019
- 2019-04-04 HU HUP1900112A patent/HU231498B1/hu unknown
-
2020
- 2020-03-25 JP JP2021558539A patent/JP7333412B2/ja active Active
- 2020-03-25 US US17/601,197 patent/US20220194981A1/en active Pending
- 2020-03-25 AU AU2020252054A patent/AU2020252054A1/en active Pending
- 2020-03-25 MA MA055503A patent/MA55503A/fr unknown
- 2020-03-25 CN CN202080026805.7A patent/CN113710685A/zh active Pending
- 2020-03-25 KR KR1020217034512A patent/KR20210149089A/ko not_active Application Discontinuation
- 2020-03-25 BR BR112021017206A patent/BR112021017206A2/pt unknown
- 2020-03-25 CA CA3130629A patent/CA3130629A1/fr active Pending
- 2020-03-25 WO PCT/EP2020/058439 patent/WO2020200980A1/fr active Application Filing
- 2020-03-25 EP EP20716409.6A patent/EP3947414A1/fr active Pending
-
2021
- 2021-09-14 SA SA521430291A patent/SA521430291B1/ar unknown
Also Published As
Publication number | Publication date |
---|---|
AU2020252054A1 (en) | 2021-09-16 |
SA521430291B1 (ar) | 2024-03-03 |
KR20210149089A (ko) | 2021-12-08 |
HU231498B1 (hu) | 2024-05-28 |
US20220194981A1 (en) | 2022-06-23 |
WO2020200980A1 (fr) | 2020-10-08 |
EP3947414A1 (fr) | 2022-02-09 |
BR112021017206A2 (pt) | 2021-12-14 |
HUP1900112A1 (hu) | 2020-10-28 |
JP2022526965A (ja) | 2022-05-27 |
CN113710685A (zh) | 2021-11-26 |
CA3130629A1 (fr) | 2020-10-08 |
JP7333412B2 (ja) | 2023-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA55503A (fr) | Amélioration de la chromatographie d'affinité d'immunoglobulines au moyen d'une floculation de pré-capture | |
EA201992163A1 (ru) | АНТИТЕЛА К БЕТА-АМИЛОИДНОМУ ПЕПТИДУ N3pGlu И ИХ ПРИМЕНЕНИЕ | |
EA201792184A1 (ru) | Антитела, направленные против т-клеточного иммуноглобулина и белка муцина 3 (tim-3) | |
EA201892362A1 (ru) | Агонистические антитела, которые связываются с cd40 человека, и варианты их применения | |
EA201791590A1 (ru) | Антитела к tau и их применение | |
EA201300320A1 (ru) | Моноклональные антитела человека к киназе-1, подобной рецептору активина | |
FR3047794B1 (fr) | Systeme de lentilles de projection d'au moins une source lumineuse | |
EA202192146A1 (ru) | Антитела к клаудину 6 и их применение | |
EA201991729A1 (ru) | Антитела к tgf-бета и их применение | |
MA54078A (fr) | Méthodes pour le traitement au moyen de récepteurs antigéniques chimériques spécifiques de l'antigene de maturation des lymphocytes b | |
MA47221A1 (fr) | Anticorps monoclonal à pd-l1 | |
MA50280A (fr) | Procédés et compositions pour améliorer l'immunogénicité de tumeurs [ | |
MA46842A (fr) | Méthodes de traitement de l'obésité au moyen d'anticorps anti-angptl8 | |
EA202090262A1 (ru) | Очистка белка | |
EA201991726A1 (ru) | Гуманизированное антитело для лечения или предотвращения когнитивных расстройств, способ его получения и агент для лечения или предотвращения когнитивных расстройств с его применением | |
EA202191656A1 (ru) | Анти-il-36 антитела и способы их применения | |
EA201892440A1 (ru) | Антитела к tl1a и их применения | |
MA54468A (fr) | Constructions de protéines de fusion pour une maladie associée au complément | |
EA202191231A1 (ru) | СПОСОБЫ ЛЕЧЕНИЯ ЭНДОКРИННОЙ ОФТАЛЬМОПАТИИ С ПРИМЕНЕНИЕМ АНТИ-FcRn АНТИТЕЛ | |
EA202191769A1 (ru) | Тубулизины и конъюгаты белок-тубулизин | |
EA201992688A1 (ru) | Средства, пути применения и способы лечения | |
EA202192786A1 (ru) | Твердые формы (e)-3-[2-(2-тиенил)винил]-1h-пиразола | |
MA54975A1 (fr) | Anticorps anti-pcrv qui se lient à pcrv, compositions comprenant des anticorps anti-pcrv, et leurs méthodes d'utilisation | |
MA53094A (fr) | Protéine de liaison à l'antigène anti-steap1 | |
EA201992883A1 (ru) | АНТИТЕЛА К TrkB |